Search results for: 'should commens partnering 2016 2017'
- Did you mean
- shield commens partnering 221b 2017
- Related search terms
- partnering agreement white world leading biopharma compani
- partnering agreements work biocryst pharmaceutical 2016 2016
- should+cover+partnering+2025+2025
- should+copi+partnering+2025+2025
- partnering agreements with amag pharmaceutical 2025 2016
-
Autoimmune Collaboration and Licensing Deals 2016-2026April 2026$3,995.00Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cell Therapy Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cell Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Gene Therapy Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Gene Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Diagnostic Imaging Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Distribution Deals in Medical Devices 2016-2026March 2026$3,995.00Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Antibiotic Collaboration and Licensing Deals 2016-2025July 2025$3,995.00Antibiotic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
